Trial Profile
A Study to Evaluate the Factors Associated with Positive Changes in Health Outcomes in Inflammatory Bowel Diseases (IBD) Patients Treated with Infliximab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 23 Dec 2015 New trial record